This is a routine plan-level acquisition with no trading signal. No action warranted, monitor for any open-market insider buying or selling patterns in future filings.
GSK drugs
GSK drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 11 $50.90entry
- T+1 · 3mo ago −1.18%α −1.43% · $50.30
- T+5 · 3mo ago +0.49%α +0.89% · $51.15
- T+20 · 2mo ago −4.46%α −3.40% · $48.63
- T+60 · 13d ago +0.49%α +0.63% · $51.15
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
GSK filed a Form 6-K reporting a routine transaction by Maya Martinez-Davis, President US, who acquired 9.016 notional ADS at $52.96 within her Executive Supplemental Savings Plan account. This is a standard compensation-related plan acquisition with no material financial impact or strategic significance.
Key Facts
- Maya Martinez-Davis, President US, acquired 9.016 notional ADS at $52.96 per ADS on August 7, 2026.
- The acquisition was made within the GSK Executive Supplemental Savings Plan account, a routine compensation plan transaction.
- The filing is a standard PDMR transaction notification with no material financial or operational information.
Financial Impact
Negligible, $477.50 total notional value (9.016 shares × $52.96).
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-007453 |
| Document: 0001654954-26-007453-index-headers.html | 0001654954-26-007453 |
| Document: 0001654954-26-007453-index.html | 0001654954-26-007453 |
| Document: 0001654954-26-007453.txt | 0001654954-26-007453 |
Track record
64 reports on GSK
9 of 18 bullish or bearish reports moved the stock their way by T+20. Best: +9.35% at T+60 after the Jul 17, 2026 report. 15 of 21 went positive at some point.
Filters
- Nov 13, 20263d ago 6-K Neutral 4/10 Entry $50.45 Now $50.41 −0.08% settles Dec 14
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $50.64 Now $50.41 −0.45% settles Dec 11
- Nov 6, 202610d ago 6-K Neutral 1/10 Entry $50.33 Now $50.41 +0.16% settles Dec 7
- Nov 2, 202614d ago 6-K Neutral 1/10 Entry $49.13 Now $50.41 +2.61% settles Dec 1
- Oct 28, 202619d ago 6-K Neutral 5/10 Entry $48.74 Now $50.41 +3.43% settles Nov 25
- Oct 26, 202621d ago 6-K Bullish 5/10 Entry $51.10 Now $50.41 −1.35% settles Nov 23
- Oct 26, 202621d ago 6-K Neutral 1/10 Entry $51.10 Now $50.41 −1.35% settles Nov 23
- Oct 26, 202621d ago 6-K Bullish 5/10 Entry $51.10 Now $50.41 −1.35% settles Nov 23
- Oct 26, 202621d ago 6-K Neutral 4/10 Entry $51.10 Now $50.41 −1.35% settles Nov 23
- Oct 21, 202626d ago 6-K Bullish 7/10 Entry $50.02 Now $50.41 +0.78% settles Nov 18
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers